Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1207 of 6351
-
Could targeted drug dosing stamp out malaria in thai hotspots?
Prevention CompletedThis study assesses the effectiveness of reactive focal mass drug administration (rfMDA), targeting both village and forest working populations, compared to control for reducing the health promotion hospital-level (sub-district) incidence and prevalence of P. falciparum and P. vi…
Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Glowing dye could help surgeons spot hidden brain tumor cells
Diagnosis CompletedThis Phase 3 open-label single-arm study is designed to investigate the safety, diagnostic performance, and clinical usefulness of Gleolan for the real time detection and visualization of meningiomas during tumor resection surgery. The study is planned to run for 15 months with i…
Phase 3 • Sponsor: NX Development Corp • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
New eye drug implant could reduce injections for wet AMD
Disease control OngoingThis is a first in-human study to investigate the safety, tolerability and efficacy of zifibancimig administered through intravitreal (IVT) injections and via the port delivery (PD) implant in participants with neovascular age-related macular degeneration (nAMD).
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Nurse-Led phone program aims to cut stroke risk in ghana
Disease control CompletedThe overall objective of Phone-based Intervention under Nurse Guidance after Stroke II (PINGS-2) is to deploy a hybrid study design to firstly, demonstrate the efficacy of a theoretical-model-based, mHealth technology-centered, nurse-led, multi-level integrated approach to substa…
Phase 3 • Sponsor: Northern California Institute of Research and Education • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Engineered immune cells take aim at Tough-to-Treat leukemia
Disease control Stopped earlyThis phase 1 study will evaluate the safety and efficacy of a CAR-T cell therapy directed against two B cell antigens (CD19 CD20) and produced under good manufacturing practice (GMP) conditions using the closed system CliniMACS Prodigy device in B ALL.
Phase 1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New study aims to match pancreatic cancer patients with best chemo
Disease control CompletedThis is a randomized multicentre phase II trial with a large translational component. The trial will evaluate the two standard chemotherapy regimens: modified folfirinox (mFFX) and gemcitabine/nab-paclitaxel (GA), in patients with untreated metastatic pancreatic ductal adenocarci…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a pill shrink bladder tumors before surgery?
Disease control CompletedThis phase II trial studies how well Pemigatinib (an orally administered inhibitor of fibroblast growth factor receptors 1, 2, and 3) works in non-muscle invasive bladder cancer (NMIBC) patients with recurrent tumors and a prior history of low- or intermediate-risk NMIBC tumors. …
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Lifestyle overhaul may reverse metabolic syndrome in overweight individuals
Disease control CompletedThis is a randomized, prospective clinical trial investigating metabolic syndrome in overweight or obese Chinese individuals. The study aims to evaluate the efficacy of a structured intensive lifestyle intervention program in achieving significant weight reduction (targeting 15% …
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Immunotherapy-Chemo combo takes on advanced sarcoma
Disease control Recruiting nowThis study is being done to find out whether the study drug Retifanlimab, a monoclonal antibody against the PD-1 protein, combined with gemcitabine and docetaxel, is a safe and effective treatment for your disease. Gemcitabine and docetaxel are chemotherapy drugs that are commonl…
Phase 1/2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
20,000 volunteers join quest to detect pancreatic cancer sooner
Knowledge-focused Recruiting nowThe purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal adenocarcinoma (PDAC) by establishing a multisite cohort of individuals with family history of PDAC and/or i…
Sponsor: Arbor Research Collaborative for Health • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Ancient herbal mix put to the test against childhood eczema
Disease control Recruiting nowThe study aims to evaluate the clinical efficacy and safety of the modified Qing-Ying Decoction (mQYD) for the treatment of subacute and chronic atopic dermatitis (AD) in children when compared to the placebo control through examining the clinical symptoms, quality of life, gut m…
Phase 2/3 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Radiation before chemo: a new strategy to fight High-Risk breast cancer?
Disease control OngoingPatients with high risk breast cancers (any locally advanced breast cancer patient defined as Stages IIB-III \[excluding inflammatory breast cancer\] with stage IIA being eligible for triple negative and HER2-positive breast cancers) will receive neoadjuvant radiation to any port…
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Thousands of cancer patients enrolled in massive immunotherapy observation study
Knowledge-focused Recruiting nowThis prospective, multicenter observational study included all patients with solid neoplasms who received treatment with immune checkpoint inhibitors (ICIs) in clinical practice, regardless of tumor type, tumor stage, type of immunotherapy, or treatment lines. This study aimed to…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New study tests which drug gives myeloma patients better daily life
Disease control OngoingThe purpose of this study is to compare maintenance therapy approaches in people with newly diagnosed multiple myeloma (MM) that has responded well to a first round of treatment. The researchers will compare giving the usual maintenance therapy (lenalidomide) with giving daratumu…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 15:39 UTC
-
Bionic breakthrough: implant gives amputees sense of touch
Disease control Recruiting nowThe purpose of this research is to gather information on the safety and effectiveness of an implanted wireless sensory enabled highly intuitive controlled prosthetic device.
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Simple painkiller may stop Post-Surgery brain fog in seniors
Prevention CompletedOur objective is to find an effective prophylactic intervention by evaluating IV acetaminophen's impact in reducing the frequency of postoperative delirium, one of the most common and detrimental complications of cardiac surgery in older adults.
Phase 3 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:06 UTC
-
Personalized sleep apnea treatment on the horizon?
Knowledge-focused CompletedThis study will investigate why some people have Obstructive Sleep Apnea (OSA) and how the underlying cause may relate to OSA manifestations (including sleepiness and high blood pressure) and response to different therapeutic approaches (ie CPAP, eszopiclone, and supplemental oxy…
Phase 2 • Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New stent graft aims to prevent deadly aneurysm rupture
Disease control OngoingThe INNER-B post-market clinical follow-up study is undertaken to evaluate the prevention of death related to a thoracoabdominal aneurysm when treated by the E-nside TAAA Multibranch Stent Graft System. The secondary objective is to evaluate the safety and clinical performance o…
Sponsor: JOTEC GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New study aims to catch pancreatic cancer early in High-Risk individuals
Diagnosis Recruiting nowThe investigators' goal is to conduct a prospective multicenter study to evaluate the yield and outcomes of screening of pancreas cancer in individuals who are at-risk for pancreatic cancer. We plan to use International Cancer of the Pancreas Screening (CAPS3) Consortium recommen…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Robot or scalpel? european trial tests less invasive pancreatic cancer surgery
Disease control CompletedObjective: To compare MIDP with ODP regarding radical resection rate for pancreatic ductal adenocarcinoma (PDAC) in the pancreatic body or tail. Study design: A pan-European, randomized controlled, multicenter, patient-blinded non-inferiority trial. This protocol was designed ac…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC